Lodoxamide tromethamine treatment for superior limbic keratoconjunctivitis.

Abstract

PURPOSE:

We studied the efficacy of topically applied lodoxamide tromethamine 0.1% in the treatment of superior limbic keratoconjunctivitis.

METHODS:

Three patients with clinical findings of bilateral superior limbic keratoconjunctivitis. were treated with topical lodoxamide tromethamine four times daily in both eyes.

RESULTS:

While the patients were taking lodoxamide tromethamine, symptoms and objective findings resolved.

CONCLUSIONS:

Topically applied lodoxamide tromethamine 0.1% is useful in the treatment of superior limbic keratoconjunctivitis. There may be a role for mast cell stabilizers in the treatment of this disorder.

• Authors: R D Grutzmacher, R S Foster, L S Feiler
• Journal: American journal of ophthalmology (Am J Ophthalmol) Vol. 120 Issue 3 Pg. 400-2 (Sep 1995) ISSN: 0002-9394 [Print] United States
• PMID: 7661218 (Publication Type: Case Reports, Journal Article)

Chemical References

• Histamine H1 Antagonists
• Nitriles
• Ophthalmic Solutions
• Tromethamine
• lodoxamide tromethamine
• Oxamic Acid

Topics

• Administration, Topical
• Adult
• Conjunctiva (drug effects)
• Female
• Histamine H1 Antagonists (administration & dosage, therapeutic use)
• Humans
• Keratoconjunctivitis (drug therapy)
• Male
• Middle Aged
• Nitriles
• Ophthalmic Solutions
• Oxamic Acid (administration & dosage, analogs & derivatives, therapeutic use)
• Tromethamine (administration & dosage, analogs & derivatives, therapeutic use)